A Division of P&E Associates Limited, Inc.
14902 Preston Road, #404-744, Dallas, TX 75254   Phone: 972-517-1254   FAX: 775-252-7109
HOME
Programs & Strategies
Racial Disparities in Clinical Trials: Statement of Need
Patient Outreach & Recruitment Development (P.O.R.D.)
Clinical Trials Disease Groups
Sample Outreach for Numbers
Minority Leader Survey Results about Clinical Trials

National Baptist Congress Survey

Patient Recruitment Outreach
Biotechnology & Pharmaceuticals

Capabilities Presentation

Product Launches
Relationship Marketing
Business Prospecting
Business Consulting
Our Team
Contact Us

 

 

 

 

 

 

 

 

  Health Services Telemarketing and Market Research

Consultants generate quality Institutional leads by surveying National Hospital Executives and decision-makers: CEO, CFO and COO, etc. to determine if they can benefit from added revenue by utilizing Medical and Clinical Trials or other Medical Services. We document those who qualify for follow-up, and gage their interest in your company calling them BACK to provide more information on or to set up a conference call.

Understanding that this highest level of contact takes several calls to reach decision-maker, P&E Associates delivers leads to clients on a weekly basis or within 36 hours of receipt of lead.

A minimum of two Consultants will be assigned to your calling project, each working with TARGETED Hospital lists or contact information provided from Client, that from 4-8 or more average QUALITY LEADS/week is anticipated (based upon Quality of Client’s Call List).

P&E Associates provides "Quality Leads" - This means we give you a decision-maker or key representative of decision-maker who can schedule conference call (with deciding individual, group or committee), and one who verbally agrees to speak with your company’s Representative on call-back in order to do so.

Our B2B LEAD GENERATION provides YOU WITH "HOT Leads LIST "

(people who are EXPECTING A CALL BACK) and, which averages 89% direct response upon follow-up.

A customized presentation will be given to companies interested in expanding their clinical trials patient education and recruitment program.